The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
- PMID: 30288416
- PMCID: PMC6132828
- DOI: 10.1177/2381468317692806
The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
Abstract
Background: Mapping can be performed to predict utility values from condition-specific measures when preference-based measures are absent. A previously developed algorithm that predicts EQ-5D-3L index values from the Multiple Sclerosis Impact Scale (MSIS-29) has not yet been externally validated. Aim: To examine the external validity of a previously developed mapping algorithm by testing the accuracy of predicting EQ-5D-3L index values from MSIS-29 among multiple sclerosis (MS) patients in Sweden. Methods: Cross-sectional individual-level data were collected from population-based Swedish registers between 2011 and 2014. Health-related quality of life was assessed through MSIS-29 and EQ-5D-3L at one point in time among 767 individuals with known disability level of MS. A previously developed mapping algorithm was applied to predict EQ-5D index values from MSIS-29 items, and the predictive accuracy was assessed through mean absolute error and root mean square error. Results: When applying the algorithm, the predicted mean EQ-5D-3L index value was 0.77 compared to the observed mean index value of 0.75. Prediction error was higher for individuals reporting EQ-5D values <0.5 compared to individuals reporting EQ-5D values ≥0.5. Mean absolute error (0.12) and root mean square error (0.18) were smaller or equal to the prediction errors found in the original mapping study. Conclusion: The mapping algorithm had similar predictive accuracy in the two independent samples although results showed that the highest predictive performance was found in groups with better health. Varied predictive accuracy in subgroups is consistent with previous studies and strategies to deal with this are warranted.
Keywords: EQ-5D; MSIS-29; health-related quality of life; mapping; multiple sclerosis.
Figures
Similar articles
-
Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.Med Decis Making. 2012 Jul-Aug;32(4):554-68. doi: 10.1177/0272989X11427761. Epub 2011 Nov 22. Med Decis Making. 2012. PMID: 22114301
-
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.Patient Relat Outcome Meas. 2016 Feb 3;7:13-8. doi: 10.2147/PROM.S96956. eCollection 2016. Patient Relat Outcome Meas. 2016. PMID: 26893584 Free PMC article.
-
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4. Value Health. 2012. PMID: 23244811 Clinical Trial.
-
Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.Health Qual Life Outcomes. 2022 Dec 15;20(1):164. doi: 10.1186/s12955-022-02076-9. Health Qual Life Outcomes. 2022. PMID: 36522665 Free PMC article.
-
NICE DSU Technical Support Document 10: The Use of Mapping Methods to Estimate Health State Utility Values [Internet].London: National Institute for Health and Care Excellence (NICE); 2011 Apr. London: National Institute for Health and Care Excellence (NICE); 2011 Apr. PMID: 28481491 Free Books & Documents. Review.
Cited by
-
Predictive ability of the American Society of Anaesthesiologists physical status classification system on health-related quality of life of patients after total hip replacement: comparisons across eight EQ-5D-3L value sets.BMC Musculoskelet Disord. 2020 Jul 6;21(1):441. doi: 10.1186/s12891-020-03399-8. BMC Musculoskelet Disord. 2020. PMID: 32631419 Free PMC article.
-
Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).Health Qual Life Outcomes. 2019 Aug 5;17(1):136. doi: 10.1186/s12955-019-1205-y. Health Qual Life Outcomes. 2019. PMID: 31382960 Free PMC article.
-
Comparison of employment among people with Multiple Sclerosis across Europe.Mult Scler J Exp Transl Clin. 2022 Apr 27;8(2):20552173221090653. doi: 10.1177/20552173221090653. eCollection 2022 Apr-Jun. Mult Scler J Exp Transl Clin. 2022. PMID: 35496757 Free PMC article.
-
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab.Mult Scler J Exp Transl Clin. 2024 May 26;10(2):20552173241252566. doi: 10.1177/20552173241252566. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38807848 Free PMC article.
-
Health-Related Quality of Life in Long COVID: Mapping the Condition-Specific C19-YRSm Measure Onto the EQ-5D-5L.Patient Relat Outcome Meas. 2025 Jan 25;16:55-66. doi: 10.2147/PROM.S490870. eCollection 2025. Patient Relat Outcome Meas. 2025. PMID: 39882499 Free PMC article.
References
-
- Vollmer T. The natural history of relapses in multiple sclerosis. J Neurol Sci. 2007;256(Suppl. 1):S5–13. - PubMed
-
- Tinghog P, Hillert J, Kjeldgard L, Wiberg M, Glaser A, Alexanderson K. High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study. Mult Scler. 2013;19(14):1923–30. - PubMed
-
- Karampampa K, Gustavsson A, Miltenburger C, Eckert B. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries. Mult Scler. 2012;18(2 Suppl.):7–15. - PubMed
-
- Naci H, Fleurence R, Birt J, Duhig A. The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature. J Med Econ. 2010;13(1):78–89. - PubMed
LinkOut - more resources
Full Text Sources